Allen Webb
First SEC filing: March 5, 2020 · Latest: March 5, 2020
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 3, 2020 | XRN | A | 20,780 | · | · | 92,582 Direct | +28.94% | Acquired | (price as of 2026-10-02) |
| March 3, 2020 | XRN | A | 3,626 | · | · | 71,802 Direct | +5.32% | Acquired | (price as of 2026-10-02) |
| March 3, 2020 | XRN | A | 10,924 | · | · | 68,176 Direct | +19.08% | Acquired | (price as of 2026-10-02) |
| March 5, 2019 | XRN | A | 2,470 | · | · | 57,252 Direct | +4.51% | Acquired | (price as of 2026-10-02) |
| March 5, 2019 | XRN | A | 5,164 | · | · | 54,782 Direct | +10.41% | Acquired | (price as of 2026-10-02) |
| March 5, 2019 | XRN | A | 9,031 | · | · | 49,618 Direct | +22.25% | Acquired | (price as of 2026-10-02) |
| March 5, 2018 | XRN | A | 7,196 | · | · | 40,587 Direct | +21.55% | Acquired | (price as of 2026-10-02) |
| March 5, 2018 | XRN | A | 7,961 | · | · | 33,391 Direct | +31.31% | Acquired | (price as of 2026-10-02) |
| Dec. 21, 2016 | XRN | A | 5,430 | · | · | 25,430 Direct | +27.15% | Acquired | (price as of 2026-10-02) |
| July 1, 2016 | XRN | A | 4,000 | · | · | 20,000 Direct | +25.00% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock | · | · | 20,780 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock | · | · | 3,626 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 10,924 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F5] | Common Stock | · | · | 2,470 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock | · | · | 5,164 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 9,031 | Acquired |
| March 5, 2018 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock | · | · | 7,196 | Acquired |
| March 5, 2018 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 7,961 | Acquired |
| Dec. 21, 2016 | XRN | LTIP Unit [F1] | Common Stock | · | · | 5,430 | Acquired |
| July 1, 2016 | XRN | LTIP Unit [F1] | Common Stock | · | · | 4,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | · | · | $217,344 | · | · | · | · | $253,150 |
| 2017 | · | · | $170,004 | · | · | · | · | $190,348 |
| 2016 | · | · | $250,010 | · | · | · | · | $254,010 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.